Atlas Trials

Open-label Extension of the HOPE-2 Trial

Clinical trial NCT04428476 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04428476
Sponsor
Capricor Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2020-08-05
Primary completion
2022-02-16
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.